PCI Pharma Services Announces Multi-Million Dollar Expansion to UK Manufacturing Facility to Meet Growing Demand for Global High Potent Manufacturing Services Supporting Oncology Treatments | Business Wire
Impact of COVID-19 on primary percutaneous coronary intervention centres in the UK: a survey